LABP

Landos Biopharma, Inc. Common Stock

Delisted

LABP was delisted on the 23rd of May, 2024.

47 hedge funds and large institutions have $219M invested in Landos Biopharma, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 46 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$141M
2 +$38.3M
3 +$7.07M
4
O
OrbiMed
New York
+$6.56M
5
DM
Deerfield Management
New York
+$4.33M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
26
$148K
27
$130K
28
$98K
29
$98K
30
$96K
31
$96K
32
$92K
33
$70K
34
$38K
35
$19K
36
$18K
37
$14.4K
38
$14K
39
$10K
40
$6K
41
$6K
42
$5K
43
$5K
44
$4K
45
$2K
46
$1K
47
$35